Cann Group Limited
ASX:CAN.AX
0.04 (AUD) • At close September 16, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Cann Group Limited |
Symbool | CAN.AX |
Munteenheid | AUD |
Prijs | 0.038 |
Beurswaarde | 17,819,606 |
Dividendpercentage | 0% |
52-weken bereik | 0.027 - 0.19 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Peter Koetsier |
Website | https://www.canngrouplimited.com |
An error occurred while fetching data.
Over Cann Group Limited
Cann Group Limited engages in the breeding, cultivation, production, manufacturing, clinical evaluation, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets. It licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (AUD)
Cijfers zijn in miljoenen (AUD)